Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

Clinical trial NCT06914050 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06914050
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Small Cell Limited-stage Small Cell Lung Cancer (LS-SCLC)

Start date: 2025-04-01
Primary completion: 2026-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.